# FDA Inspection 1249411 - Ewa Springer, M.D., Ph.D. - September 06, 2024

Source: https://www.keypedia.com/records/fda_inspections/ewa-springer-md-phd/f5e06c75-650a-431f-88d5-a9b8e4ce596c
Source feed: FDA_Inspections

> FDA Inspection 1249411 for Ewa Springer, M.D., Ph.D. on September 06, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249411
- Company Name: Ewa Springer, M.D., Ph.D.
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1249411 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/ewa-springer-md-phd/66b8cdac-4abd-43c2-9700-9be4b8e7ce61)

Company: https://www.keypedia.com/companies/ewa-springer-md-phd/66474b81-e49b-4ef5-82de-de9c7dcc3cce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c